Manatuck Hill Partners »

Exagen shares owned by Manatuck Hill Partners

Quarter-by-quarter ownership of Exagen (XGN) shares owned by Manatuck Hill Partners from 13F filings

Historical chart of Manatuck Hill Partners investment in Exagen

Tip: Access up to 7 years of quarterly data

All positions including Exagen held by Manatuck Hill Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Exagen by Manatuck Hill Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.9M 175k 10.99
2025-06-30 $1.2M 175k 6.98

More positions owned by Manatuck Hill Partners

Zeta Global Holdings Corp Cl A (ZETA)
Realreal (REAL)
Imax Corp Cad (IMAX)
Optimizerx Corp Com New (OPRX)
Herbalife Com Shs (HLF)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
HSBC HLDGS Spon Adr New (HSBC)
Magnite Ord (MGNI)
Technipfmc (FTI)
Sprott Asset Management Physical Gold Tr (PHYS)
National HealthCare Corporation (NHC)
Carriage Services (CSV)
Bank of America Corporation (BAC)
TETRA Technologies (TTI)
Sprott Asset Management Physical Silver (PSLV)

View all positions for Manatuck Hill Partners

Top funds holding Exagen

Rtw Investments
Vanguard Group
Balyasny Asset Management
Invesco
Kennedy Capital Management
Morgan Stanley
Silvercrest Asset Management Group
Wexford Capital
Millennium Management
Two Sigma Investments
Russell Investments
FourWorld Capital Management
Susquehanna International
Manatuck Hill Partners
Geode Capital Management

View all funds holding Exagen